36. Epidermolysis bullosa Clinical trials / Disease details


Clinical trials : 163 Drugs : 185 - (DrugBank : 46) / Drug target genes : 50 - Drug target pathways : 125

  
1 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT03730584
(ClinicalTrials.gov)
February 27, 20172/11/2018Evaluation of the Efficacy of ROPIVACAINE in Children and Young Adults With Hereditary Epidermolysis BullosaEvaluation of the Efficacy of a Topical Analgesic Treatment With ROPIVACAINE in Children and Young Adults With Hereditary Epidermolysis BullosaEpidermolysis BullosaDrug: Ropivacaine;Biological: Blood testAssistance Publique - Hôpitaux de ParisNULLCompletedN/A21 YearsAll10N/AFrance